Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NITROGEN-CONTAINING CONDENSED HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2012/124744
Kind Code:
A1
Abstract:
Provided is a compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, having superior monoacylglycerol acyltransferase-2 inhibitory activity. In formula (I), ring (A) represents a partially saturated heteroaryl group, an aryl group, or a heteroaryl group; RB represents a C4-18 alkyl group, a C3-8 cycloalkyl group, a partially saturated aryl group, an aryl group, or formula (II) (in formula (II), V represents the formula -CR11R12-, the formula -CO-, the formula -CO-O-, or the formula -CO-NH-; W represents a single bond or a C1-3 alkylene group; and the ring (B) represents a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a partially saturated heteroaryl group, a saturated heterocyclyl group, an aryl group, or a heteroaryl group); Y represents a nitrogen atom or formula N+(RF); RF represents a C1-4 alkyl group; and m and n may be the same or different and each independently represent an integer 0 or 1.

Inventors:
BUSUJIMA TSUYOSHI (JP)
OI TAKAHIRO (JP)
TANAKA HIROAKI (JP)
SHIRASAKI YOSHIHISA (JP)
IWAKIRI KANAKO (JP)
SATO NAGAAKI (JP)
TOKITA SHIGERU (JP)
Application Number:
PCT/JP2012/056600
Publication Date:
September 20, 2012
Filing Date:
March 14, 2012
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAISHO PHARMACEUTICAL CO LTD (JP)
BUSUJIMA TSUYOSHI (JP)
OI TAKAHIRO (JP)
TANAKA HIROAKI (JP)
SHIRASAKI YOSHIHISA (JP)
IWAKIRI KANAKO (JP)
SATO NAGAAKI (JP)
TOKITA SHIGERU (JP)
International Classes:
C07D209/44; A61K31/4035; A61K31/454; A61K31/472; A61K31/4725; A61K31/497; A61K31/498; A61K31/506; A61K31/538; A61K31/55; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12; A61P43/00; C07D217/04; C07D217/06; C07D217/22; C07D223/16; C07D401/06; C07D401/10; C07D401/12; C07D403/12; C07D405/06; C07D405/12; C07D413/12; C07D417/06
Domestic Patent References:
WO2010095767A12010-08-26
WO2008038768A12008-04-03
WO2012013716A12012-02-02
WO2006051662A12006-05-18
WO2006095822A12006-09-14
WO2008038768A12008-04-03
WO2010095767A12010-08-26
WO2006122014A22006-11-16
WO1996033993A11996-10-31
WO2010011375A22010-01-28
Foreign References:
JP2008540539A2008-11-20
JPH09512275A1997-12-09
JP2007514731A2007-06-07
US4315935A1982-02-16
JP2008001635A2008-01-10
Other References:
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 16, 2003, pages 13860
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 20, 2003, pages 18532
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 279, no. 18, 2004, pages 18878
NATURE MEDICINE, vol. 15, no. 4, 2009, pages 442
JOURNAL OF ORGANIC CHEMISTRY, vol. 23, 1980, pages 837
SYNTHESIS, 1980, pages 425
TETRAHEDRON LETTERS, vol. 43, 2002, pages 7247
TETRAHEDRON LETTERS, vol. 36, 1995, pages 2531
TETRAHEDRON LETTERS, vol. 37, 1996, pages 2463
TETRAHEDRON LETTERS, vol. 20, 1979, pages 3437
CHEMICAL REVIEWS, vol. 95, 1995, pages 2457
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 13, 2005, pages 1201
JOHN F. LOCKWOOD ET AL., AM. J. PHYSIOL. ENDOCRINOL. METAB, vol. 285, 2003, pages E927
JOHN F. LOCKWOOD ET AL., AM. J. PHYSIOL. ENDOCRINOL. METAB., vol. 285, 2003, pages E927
See also references of EP 2687507A4
Attorney, Agent or Firm:
ONO, Shinjiro et al. (JP)
Ono Shinjiro (JP)
Download PDF:
Claims: